Post
Norgine seeks approval for high-risk neuroblastoma treatment
Norgine has sought approval for eflornithine (difluoromethylornithine [DFMO]) for the treatment of patients with high-risk neuroblastoma (HRNB). The development marks the …
Sanofi signs mRNA vaccine development deal with IDT Australia
Sanofi has signed a master service agreement with IDT Australia focusing on the preclinical formulation development and current Good Manufacturing …
The cutting-edge monitoring technology that is transforming the future of clinical trials
As the pharmaceutical landscape evolves, the complexity that these innovations require for their supply chains also increases. The development of …
Marinus fails to meet early stopping criteria for status epilepticus trial
Marinus Pharmaceuticals has announced that its pivotal Phase III RAISE study (NCT04391569) of IV ganaxolone for the treatment of status …
Soligenix bags orpan drug designation for Marburg virus vaccine
The US Food and Drug Administration (FDA) has granted orphan drug designation to the active ingredient in MarVax, Soligenix’s vaccine …
Soligenix bags orpan drug designation for Marburg virus vaccine
The US Food and Drug Administration (FDA) has granted orphan drug designation to the active ingredient in MarVax, Soligenix’s vaccine …
AVEO Pharmaceuticals gets grant for decreasing blood urea nitrogen levels in hyperuricemia using anti-gdf15 antibody
AVEO Pharmaceuticals patented a method to treat renal-related disorders by inhibiting GDF15 activity. Claim 1 details administering specific anti-GDF15 antibodies …
Allscripts Healthcare Solutions gets grant for resource management system for medical software applications optimization
Allscripts Healthcare Solutions has been granted a patent for a resource management system that optimizes and distributes predictively processed data …
Ferring International Center gets grant for pharmaceutical composition for treating inflammatory bowel disease using bacteriophages
Ferring International Center has patented a pharmaceutical composition containing bacteriophages targeting adherent-invasive E. coli strains for treating inflammatory bowel disease. …
Arena Pharmaceuticals gets grant for treatment of atopic dermatitis with compound 1
Arena Pharmaceuticals has been granted a patent for a method of treating atopic dermatitis by administering a specific compound in …
Ablynx gets grant for inhibiting tumor growth by administering polypeptides binding gitr
Ablynx has been granted a patent for immunoglobulin single variable domains that bind GITR, enhancing immune response and inhibiting tumor …
ImmunityBio gets grant for cross-reactive SARS-COV2 vaccine composition for multiple coronaviruses
ImmunityBio's patent covers a recombinant SARS-CoV2 vaccine with cross-reactivity against various coronaviruses. The method involves administering the vaccine to elicit …
Atrium Health gets grant for cancer treatment using antibodies and engineered cytotoxic cells
Atrium Health has been granted a patent for methods and compositions involving antibodies with targeting ligands and engineered cytotoxic cells …
Zydus Lifesciences gets grant for oral suspension pharmaceutical composition of immunosuppressive agent
Zydus Lifesciences has been granted a patent for a pharmaceutical composition in oral suspension form. The composition includes mycophenolate mofetil, …
Ginkgo BioWorks gets grant for AAV vector for treating NPC1 with specific gene sequence
Ginkgo BioWorks has been granted a patent for gene therapy compositions and methods to treat NPC1 using Adeno-associated virus (AAV) …